Expansion Therapeutics
Bringing transformative therapies to patients with severe RNA-mediated diseases.
Jupiter, United States
29 employees
Series Unknown
Total: $142.22M
Biotechnology, Health Care +1
General Information
Get notified when Expansion Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Expansion Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Expansion Therapeutics
Taxonomy: RNA-mediated diseases, Drug discovery, Small molecule medicines, Expansion repeat diseases, Therapeutics, Jupiter, Florida, Intellectual property, RNA-targeted drug candidates, Potent small molecule binders, Biopharmaceutical, Precision medicine, Therapeutic development, Biomedical research, Drug development
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | - | 04 Jan 2023 | |
| Series B | •••••• | 9 |
|
29 Sep 2021 |
| Series A | •••••• | 1 |
|
03 Jan 2018 |
Expansion Therapeutics Alternatives & Competitors
Saverna Therapeutics aims to discover highly active, selective and cell-permeable molecules to targe...
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions o...
Save the life of rare disease patients and the parents by RNA binding molecules.
vs
Skyhawk Therapeutics
FAQ About Expansion Therapeutics
Don't just browse. Track.
Signal Tracker monitors Expansion Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.